Neuberger Berman Group’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-39,762
| Closed | -$3.11M | – | 1867 |
|
|
2021
Q1 | $3.11M | Buy |
+39,762
| New | +$3.11M | ﹤0.01% | 1061 |
|
|
2020
Q2 | – | Sell |
-1,807,951
| Closed | -$64.9M | – | 1634 |
|
|
2020
Q1 | $64.9M | Sell |
1,807,951
-45,197
| -2% | -$2.57M | 0.1% | 269 |
|
|
2019
Q4 | $131M | Buy |
1,853,148
+80,568
| +5% | +$5.84M | 0.15% | 201 |
|
|
2019
Q3 | $133M | Buy |
1,772,580
+77,852
| +5% | +$6.6M | 0.16% | 181 |
|
|
2019
Q2 | $137M | Buy |
1,694,728
+15,907
| +0.9% | +$1.12M | 0.16% | 178 |
|
|
2019
Q1 | $112M | Sell |
1,678,821
-22,545
| -1% | -$1.71M | 0.14% | 216 |
|
|
2018
Q4 | $127M | Buy |
1,701,366
+81,755
| +5% | +$6.75M | 0.18% | 169 |
|
|
2018
Q3 | $149M | Sell |
1,619,611
-23,555
| -1% | -$2.24M | 0.17% | 177 |
|
|
2018
Q2 | $162M | Buy |
1,643,166
+44,916
| +3% | +$5.02M | 0.18% | 168 |
|
|
2018
Q1 | $178M | Buy |
1,598,250
+138,567
| +9% | +$15.5M | 0.2% | 147 |
|
|
2017
Q4 | $150M | Buy |
1,459,683
+136,869
| +10% | +$13.6M | 0.17% | 186 |
|
|
2017
Q3 | $125M | Buy |
1,322,814
+87,600
| +7% | +$6.91M | 0.16% | 206 |
|
|
2017
Q2 | $96.2M | Sell |
1,235,214
-18,357
| -1% | -$1.38M | 0.12% | 248 |
|
|
2017
Q1 | $100M | Buy |
1,253,571
+61,672
| +5% | +$4.9M | 0.13% | 236 |
|
|
2016
Q4 | $93.9M | Buy |
1,191,899
+129,915
| +12% | +$10.1M | 0.13% | 245 |
|
|
2016
Q3 | $82.8M | Buy |
1,061,984
+109,230
| +11% | +$7.92M | 0.11% | 271 |
|
|
2016
Q2 | $65.5M | Buy |
952,754
+179,096
| +23% | +$12.4M | 0.09% | 299 |
|
|
2016
Q1 | $55.2M | Buy |
773,658
+8,666
| +1% | +$544K | 0.08% | 341 |
|
|
2015
Q4 | $47.5M | Buy |
764,992
+186,938
| +32% | +$11.4M | 0.06% | 388 |
|
|
2015
Q3 | $32.8M | Buy |
578,054
+65,844
| +13% | +$3.49M | 0.04% | 491 |
|
|
2015
Q2 | $27.5M | Buy |
512,210
+202,422
| +65% | +$9.85M | 0.03% | 590 |
|
|
2015
Q1 | $14.7M | Buy |
309,788
+280,954
| +974% | +$12.4M | 0.02% | 765 |
|
|
2014
Q4 | $1.25M | Buy |
+28,834
| New | +$1.18M | ﹤0.01% | 1173 |
|
Neuberger Berman Group's CMD Position: Q2 2021 in Review
Neuberger Berman Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 39,762 shares — an estimated $3.11M sold.
Neuberger Berman Group first reported a position in CMD in Q4 2014 and held it in 23 quarters. The position peaked at $178M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Neuberger Berman Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Neuberger Berman Group sold 39,762 Cantel Medical Corporation shares in Q2 2021, an estimated $3.11M.
- Neuberger Berman Group first reported a position in Cantel Medical Corporation in Q4 2014 and held it in 23 quarters.
- Neuberger Berman Group's Cantel Medical Corporation position peaked at $178M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Neuberger Berman Group's 13F filing for Q2 2021, filed 13 Aug 2021.